SMTL ID : 4bb4.1

ephB4 kinase domain inhibitor complex

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.65 Å

Oligo State

monomer

Ligands

1 x 32W: N-(2-methoxyethyl)-4-[(6-pyridin-4-ylquinazolin-2-yl)amino]benzamide(Non-covalent)

32W.1: 17 residues within 4Å: Chain A: E.22, V.23, I.24, V.32, A.48, K.50, E.67, M.71, I.94, T.96, E.97, F.98, M.99, E.100, G.102, L.150, S.160 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.24, A:I.24, A:V.32, A:A.48, A:K.50, A:T.96, A:F.98, A:L.150 Hydrogen bonds: A:I.24, A:M.99, A:M.99, A:G.102 pi-Cation interactions: A:K.50

2 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 1 residues within 4Å: Chain A: E.75 No protein-ligand interaction detected (PLIP) MG.3: 2 residues within 4Å: Chain A: D.143, D.161 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.143, A:D.161, A:D.161, H2O.5

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Vasbinder, M.M. et al., Discovery and Optimization of a Novel Series of Potent Mutant B-Raf V600E Selective Kinase Inhibitors. J.Med.Chem. (2013)

Release Date

2013-02-27

Peptides

EPHRIN TYPE-B RECEPTOR 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

EPHRIN TYPE-B RECEPTOR 4

Related Entries With Identical Sequence